Zahra Rattray is a Senior Lecturer in Translational Pharmaceutics at the University of Strathclyde Institute of Pharmacy and Biomedical Sciences. Her lab research the engineering of biologics with enhanced developability and biological function, the nuclear import pathway for drug delivery, and biologically-relevant in vitro tests for evaluating nanomedicine performance. Prior to joining Strathclyde in 2018, Zahra was a postdoctoral researcher at Yale School of Medicine where she investigated the re-engineering of cell-penetrating lupus autoantibodies as monotherapy, and for drug delivery applications. Roles prior to 2016 include: senior formulation scientist at AstraZeneca Pharmaceuticals for various parenteral and pre-clinical projects, and a postdoctoral associate at the University of Manchester focusing on protein aggregation.